Technical analysis of Cardio Diagnostics Holdings, Inc. (CDIO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Price Performance
| 1 month | +4.71% |
| 3 months | +1.01% |
| Year-to-date | -26.20% |
| 1 year | -48.19% |
| 3 years | -85.35% |
52-Week Range
| 52-week High | $7.91 |
| 52-week Low | $0.97 |
| Avg Volume (90d) | 61K |
Technical Indicators
| SMA 50 | $1.83 |
| SMA 200 | $2.25 |
| 30-day Volatility (annualised) | 84.0% |
| Price vs SMA 50 | +9.0% |
| Price vs SMA 200 | -11.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $4.04 | |
| 2025-11 | $2.88 | -28.7% |
| 2025-12 | $2.71 | -5.9% |
| 2026-01 | $1.51 | -44.3% |
| 2026-02 | $6.55 | +333.8% |
| 2026-03 | $1.95 | -70.2% |
| 2026-04 | $1.79 | -8.2% |
| 2026-05 | $1.89 | +5.6% |
| 2026-06 | $2.19 | +15.9% |
| 2026-07 | $1.56 | -28.8% |
| 2026-08 | $1.87 | +19.9% |
| 2026-09 | $2.00 | +7.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $2.00 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.80 |
| EV / EBITDA | -0.05 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.05 |
| Current Ratio | 17.15 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.61 |